Chemotherapy with Acute Leukemia As Secondary Diagnosis Without Cc/Mcc in North Carolina
MS-DRG 839: Chemotherapy with acute leukemia as secondary diagnosis without cc/mcc
Billed (list price)Actually paid (Medicare + patient)
| Hospital | City | Medicare stays | Billed | Paid | Cash price | Insurers (median) | |
|---|---|---|---|---|---|---|---|
| Duke University Hospital | Durham | – | – | – | $5,236 | $8,262$5,825–$21,125 · 9 plans | |
| Ecu Health Medical Center | Greenville | – | – | – | $36,348 | $12,138$11,492–$20,952 · 3 plans | |
| Novant Health New Hanover Regional Medical Center | Wilmington | – | – | – | – | $18,135$12,706–$25,039 · 13 plans |
Medicare: CMS, 2024 (hospitals with 11 or more Medicare stays). Cash and insurer prices: hospitals' own price files, where read; insurer figures are commercial plans only, median and 10th–90th percentile across plans.